research_capabilities_ireland

More documents

Recommendations

Info

Ireland has a long and successful track record of pharmaceutical and biopharmaceutical manufacturing, with An interesting development in recent years has been the arrival of several new companies to Ireland, further Indigenous Irish companies are also developing strongly as part of the cluster: companies supplying worldleading services to the multinational base here and globally or companies looking to develop their own an exciting period following the challenges faced by the have committed approximately $3bn to capital expenditure in Ireland, reinvesting in existing facilities and biopharmaceutical manufacturing with major investments announced in Cork, Dublin, Limerick, Waterford, Athlone Another area of growth has been in the area of highly having a breakthrough impact in areas such as oncology winning investment to develop and manufacture these to complement their ability to manufacture blockbuster drugs at large scale with an ability to develop and supply Exciting opportunities also exist in the area of drug delivery and drug product manufacturing and several companies have established capability in manufacture of novel opportunities for collaboration between companies on Irish government has funded three applied research centres: and training programmes in state-of-the-art facilities for which spans the entire pharmaceutical production chain from synthesis of the molecule, to the isolation of the solutions to contemporary manufacturing issues IDA welcomes the publication of this overview of the breadth and depth of research capability in Irish Universities and research institutes and the collaborations that are developing between these centres aimed at chemistry, I believe that these research centres, working together and with industry, will be catalytic in the further development where collaboration across disciplines concentration, collaboration is and will remain a key component in the success of the pharma and biopharma industry is a wide range of research collaborations with scored world rankings of 8th in materials science and 3rd MARTIN SHANAHAN IDA Chief Executive
CONTENTS 1 SMALL MOLECULE Synthesis 2 Crystal Growth + Design 3 2 DRUG PRODUCT + DRUG DELIVERY Formulation + Fill Finish 5 2 4 6 3 LARGE MOLECULE BIOPHARMACEUTICALS Downstream Processing 7 Upstream Processing 8 9 4 ENABLING TECHNOLOGIES Quality + Compliance 10 Process Engineering + Informatics 11 12 SYNTHESIS + SOLID STATE PHARMACEUTICAL 18 PHARMACEUTICAL MANUFACTURING TECHNOLOGY CENTRE 15 THE NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH + TRAINING
Page 1: PHARMACEUTICAL BIOPHARMACEUTICAL re
Page 5: DRUG PRODUCT LARGE MOLECULE/ BIOPHA
Page 8 and 9: 2 SMALL MOLECULE SYNTHESIS Ireland
Page 10 and 11: DRUG PRODUCT + DRUG DELIVERY
Page 12 and 13: LARGE MOLECULE/ BIOPHARMACEUTICALS
Page 14 and 15: 8 LARGE MOLECULE/ BIOPHARMACEUTICAL
Page 16 and 17: 10 ENABLING TECHNOLOGIES QUALITY +
Page 18 and 19: SYNTHESIS + SOLID STATE PHARMACEUTI
Page 20 and 21: 14 SYNTHESIS + SOLID STATE PHARMACE
Page 22 and 23: 16 THE NATIONAL INSTITUTE FOR BIOPR
Page 24 and 25: PHARMACEUTICAL MANUFACTURING TECHNO
Page 26: Research Partners

research_capabilities_ireland

Create successful ePaper yourself

Delete template?

Save as template?